🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This study consists of Part A for monotherapy and Part B for combination th...
Status
Recruiting
Location
NEXT Oncology
Start Date
2021-12-02
Trial ID
NCT05204862
Treatments Being Tested
Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2019-07-01
Trial ID
NCT05942768
Treatments Being Tested
To characterize safety, tolerability and to establish the maximum tolerated...
Status
Terminated
Location
University of Chicago
Start Date
2018-07-18
Trial ID
NCT03471351
Treatments Being Tested
This Phase 1 first-in-human study will investigate the safety, tolerability...
Status
Recruiting
Location
California Cancer Associates for Research and Excellence
Start Date
2023-11-07
Trial ID
NCT06108050
Treatments Being Tested
Chemotherapeutic agents exert significant immunomodulatory effects by influ...
Status
Recruiting
Location
the First Affiliated Hospital of Zhengzhou University
Start Date
2025-06-01
Trial ID
NCT06896422
Treatments Being Tested
The main goal of this study is to evaluate how safe and tolerable RNDO-564 ...
Status
Enrolling By Invitation
Location
UCSF Medical Center
Start Date
2025-11-17
Trial ID
NCT07218003
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of pembroliz...
Status
Withdrawn
Location
Mayo Clinic Jacksonville ( Site 0003)
Start Date
2017-08-01
Trial ID
NCT03221634
Treatments Being Tested
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
This study will evaluate efficacy and safety of anti-PD-1/PD-L1 antibodies ...
Status
Recruiting
Location
EuroCityClinic LLC
Start Date
2025-08-14
Trial ID
NCT07130032
Treatments Being Tested